Skip to main navigation Skip to search Skip to main content

Hodgkin Lymphoma, Version 1.2026

  • Ranjana H. Advani
  • , Christopher R. Kelsey
  • , Philippe Armand
  • , Celeste M. Bello
  • , Cecil M. Benitez
  • , David Bond
  • , Weina Chen
  • , Sheen Cherian
  • , Magdalena Czader
  • , Bouthaina Dabaja
  • , Megan E. Daly
  • , Zachary Frosch
  • , Leo I. Gordon
  • , Neil Hansen
  • , Alex F. Herrera
  • , Ephraim P. Hochberg
  • , Richard T. Hoppe
  • , Iris Isufi
  • , Patrick B. Johnston
  • , Kara Kelly
  • Vaishalee P. Kenkre, Justin Kline, Ryan C. Lynch, Jonathan McConathy, David Morgan, Alex Niu, Suman Paul, Rachel Rabinovitch, Ali Salavati, Dahlia Sano, Harsh Shah, Michael Spinner, Jakub Svoboda, Jane N. Winter, Joachim Yahalom, Joanna C. Yang, Sarah Montgomery, Katie Stehman
  • Stanford University
  • Duke University
  • Dana-Farber/Brigham and Women's Cancer Center
  • Moffitt Cancer Center
  • University of California at Los Angeles
  • Ohio State University
  • UT Southwestern Simmons Comprehensive Cancer Center
  • Case Western Reserve University
  • Indiana University Bloomington
  • University of Texas MD Anderson Cancer Center
  • University of California at Davis
  • Fox Chase Cancer Center
  • Northwestern University
  • University of Nebraska Medical Center
  • City of Hope National Med Center
  • Mass General Cancer Center
  • Yale University
  • Mayo Clinic Rochester, MN
  • University of Wisconsin-Madison
  • The University of Chicago
  • Fred Hutchinson Cancer Research Center
  • University of Alabama at Birmingham
  • Vanderbilt University
  • Roswell Park Comprehensive Cancer Center
  • Johns Hopkins University
  • University of Colorado Anschutz Medical Campus
  • University of Michigan, Ann Arbor
  • University of Utah
  • University of California at San Francisco
  • University of Pennsylvania
  • Memorial Sloan-Kettering Cancer Center
  • University of Washington
  • National Comprehensive Cancer Network

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Hodgkin lymphoma provide expert, multidisciplinary recommendations for the diagnosis and treatment of Hodgkin lymphoma. The panel convenes annually to update recommendations based on a review of recently published clinical trials. This selection from the NCCN Guidelines for Hodgkin Lymphoma focuses on the management of newly diagnosed and relapsed/refractory classic Hodgkin lymphoma in adults aged 18 to 60 years.

Original languageEnglish
Pages (from-to)41-60
Number of pages20
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume24
Issue number2
DOIs
StatePublished - Feb 2026

Fingerprint

Dive into the research topics of 'Hodgkin Lymphoma, Version 1.2026'. Together they form a unique fingerprint.

Cite this